Table 2.
Incidence and severity of myoclonus after etomidate injection in control patients and patients who received transcutaneous acupoint electrical stimulation (TAES) and/or low-dose sufentanil pretreatment before etomidate injection.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.